Kohle Districon (Charcoal, Activated)

Activated charcoal works by providing a highly porous surface that physically binds a wide variety of molecules through adsorption. When taken orally, the charcoal particles remain in the gastrointestinal tract, attaching to toxins, gases, and other substances, which prevents their absorption into the bloodstream and allows them to be eliminated in the feces.

The dose of Kohle Districon is individualized and set by the prescribing healthcare professional based on the patient’s age, weight, the nature of the toxin involved, and the clinical situation. No fixed dosing regimen is provided here; clinicians calculate the appropriate amount according to established medical guidelines.

Safety data for activated charcoal in pregnancy and lactation are limited. Because the product may bind nutrients as well as toxins, it should be used only if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate each case carefully before prescribing.

To order Kohle Districon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling) and the necessary import documentation.

The primary alternative to activated charcoal is other oral adsorbents such as sodium polystyrene sulfonate, which target specific ions rather than a broad spectrum of toxins. Activated charcoal, as in Kohle Districon, offers non‑selective adsorption of many organic compounds, making it the preferred choice for general poisoning and decontamination, whereas alternatives are usually reserved for specific electrolyte disorders.

Kohle Districon should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability and prevent contamination.

Kohle Districon is supplied as a powdered oral preparation. The powder is typically mixed with a small amount of water or another suitable liquid to form a suspension, which the patient then drinks. Administration should follow the prescriber’s instructions regarding timing relative to other oral medications.

The most serious risks include aspiration pneumonia if the product is given to patients with compromised airway protection, intestinal obstruction especially in those with pre‑existing gastrointestinal blockage, and rare hypersensitivity reactions such as rash or urticaria. Prompt medical attention is required if any of these events occur.

Kohle Districon should be avoided in patients with known gastrointestinal obstruction, perforation, or severe motility disorders, and in individuals who cannot protect their airway (e.g., unconscious or severely sedated patients). It is also contraindicated in patients with a documented allergy to activated charcoal.